Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Accounts Receivables history
Currency unavailable · from the cash flow
No Accounts Receivables data reported for this period type.
Accounts Receivables vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $16.02M USD | +90.5% | — | 22.6% | |
| LTM Mar 2026 | $10.63M USD | — | — | 4723.1% | |
| LTM Jun 2026 | $5.16M USD | +1145.6% | +46.9% | 72.4% | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| FY2025 | $0 USD | — | — | 0.0% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +618.1% | +46.9% | 47.5% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.